TY  - JOUR

T1  - Flaws in the U.S. food and drug administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients

JO  - Journal of Law, Medicine and Ethics

PY  - 2008/01/01

AU  - Ellison GTH

AU  - Kaufman JS

AU  - Head RF

AU  - Martin PA

AU  - Kahn JD

ED  - 

DO  - DOI: 10.1111/j.1748-720x.2008.290.x

VL  - 36

IS  - 3

SP  - 449

EP  - 457

Y2  - 2025/11/01

ER  -